XML 226 R97.htm IDEA: XBRL DOCUMENT
v3.24.1

Description of the Business and Summary of Significant Accounting Policies - Additional Information (Details) $ / shares in Units, $ in Thousands |  |  |  |  | 1 Months Ended | 3 Months Ended | 12 Months Ended |
--- | --- | --- | --- | --- | --- | --- | --- | ---
Dec. 11, 2023 USD ($) | Sep. 08, 2023 | Jun. 26, 2023 USD ($) shares | Jun. 22, 2023 USD ($) $ / shares shares | Apr. 30, 2023 employee | Jun. 30, 2023 | Dec. 31, 2023 USD ($) $ / shares | Dec. 31, 2022 USD ($) $ / shares | Dec. 31, 2021 USD ($) | May 31, 2023
Organization Consolidation And Presentation Of Financial Statements [Line Items] |  |  |  |  |  |  |  |  |  |
Stockholders' equity, reverse stock split |  | 1-for-25 |  |  |  |  |  |  |  |
Cost to acquire asset |  |  |  | $ 113,200 |  |  |  |  |  |
Acquired in-process research and development |  |  |  |  |  |  | $ 130,188 | $ 0 | $ 0 |
Employee workforce, termination percentage |  |  |  |  | 83.00% | 83.00% |  |  |  |
Number of employees retained | employee |  |  |  |  | 10 |  |  |  |  |
Gross proceeds received in private placement |  |  |  |  |  |  | 84,555 | 0 | $ 0 |
cash and cash equivalents |  |  |  | 3,000 |  |  | 188,893 | $ 34,863 |  |
U.S. Banking Institution |  |  |  |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements [Line Items] |  |  |  |  |  |  |  |  |  |
Cash |  |  |  | $ 2,800 |  |  |  |  |  |
Private Placement |  |  |  |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements [Line Items] |  |  |  |  |  |  |  |  |  |
Gross proceeds received in private placement | $ 180,000 |  | $ 210,000 |  |  |  | $ 180,000 |  |  |
Parapyre Option Obligation |  |  |  |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements [Line Items] |  |  |  |  |  |  |  |  |  |
Percentage of annual equity grant of options |  |  |  | 1.00% |  |  |  |  |  | 1.00%
Series A Non Voting Convertible Preferred Stock |  |  |  |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements [Line Items] |  |  |  |  |  |  |  |  |  |
Preferred stock, par value | $ / shares |  |  |  |  |  |  | $ 0.0001 | $ 0.0001 |  |
Conversion basis |  |  |  | 40 |  |  |  |  |  |
Series A Non Voting Convertible Preferred Stock | Private Placement |  |  |  |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements [Line Items] |  |  |  |  |  |  |  |  |  |
Number of shares sold in private placement | shares |  |  | 721,452 |  |  |  |  |  |  |
Gross proceeds received in private placement |  |  | $ 210,000 |  |  |  |  |  |  |
Placement agent and other offering expenses in private placement |  |  | $ 12,700 |  |  |  |  |  |  |
Asset Acquisition |  |  |  |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements [Line Items] |  |  |  |  |  |  |  |  |  |
Fixed exchange ratio |  |  |  | 0.5494488 |  |  |  |  |  |
Asset Acquisition | Spyre 2023 Equity Incentive Plan |  |  |  |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements [Line Items] |  |  |  |  |  |  |  |  |  |
Number of outstanding and unexercised stock options to purchase (in shares) | shares |  |  |  | 2,734 |  |  |  |  |  |
Asset Acquisition | Common Stock |  |  |  |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements [Line Items] |  |  |  |  |  |  |  |  |  |
Number of shares transferred as equity interest in asset acquisition | shares |  |  |  | 517,809 |  |  |  |  |  |
Asset Acquisition | Series A Non Voting Convertible Preferred Stock |  |  |  |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements [Line Items] |  |  |  |  |  |  |  |  |  |
Number of shares transferred as equity interest in asset acquisition | shares |  |  |  | 364,887 |  |  |  |  |  |
Preferred stock, par value | $ / shares |  |  |  | $ 0.0001 |  |  |  |  |  |
Conversion basis |  |  |  | 40 |  |  |  |  |  |
Spyre Therapeutics, Inc. |  |  |  |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements [Line Items] |  |  |  |  |  |  |  |  |  |
Fixed exchange ratio |  |  |  | 0.5494488 |  |  |  |  |  |
Cost to acquire asset |  |  |  | $ 113,176 |  |  |  |  |  |
Asset acquisition consideration transferred issuable shares of common stock on an as-converted basis | shares |  |  |  | 14,595,480 |  |  |  |  |  |
Acquired in-process research and development |  |  |  | $ 130,188 |  |  |  |  |  |
Asset Acquisition, net liabilities assumed |  |  |  | $ 17,000 |  |  |  |  |  |
Spyre Therapeutics, Inc. | Common Stock |  |  |  |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements [Line Items] |  |  |  |  |  |  |  |  |  |
Number of shares transferred as equity interest in asset acquisition | shares |  |  |  | 517,809 |  |  |  |  |  |
Shares issued, price per share (in dollars per share) | $ / shares |  |  |  | $ 7.277 |  |  |  |  |  |
Spyre Therapeutics, Inc. | Spyre 2023 Equity Incentive Plan |  |  |  |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements [Line Items] |  |  |  |  |  |  |  |  |  |
Number of outstanding and unexercised stock options to purchase (in shares) | shares |  |  |  | 2,734 |  |  |  |  |  |
Spyre Therapeutics, Inc. | Common Stock |  |  |  |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements [Line Items] |  |  |  |  |  |  |  |  |  |
Number of shares transferred as equity interest in asset acquisition | shares |  |  |  | 517,809 |  |  |  |  |  |
Spyre Therapeutics, Inc. | Series A Non Voting Convertible Preferred Stock |  |  |  |  |  |  |  |  |  |
Organization Consolidation And Presentation Of Financial Statements [Line Items] |  |  |  |  |  |  |  |  |  |
Number of shares transferred as equity interest in asset acquisition | shares |  |  |  | 364,887 |  |  |  |  |  |
Preferred stock, par value | $ / shares |  |  |  | $ 0.0001 |  |  |  |  |  |
Conversion basis |  |  |  | 40 |  |  |  |  |  |
Shares issued, price per share (in dollars per share) | $ / shares |  |  |  | $ 291.08 |  |  |  |  |  |

X
- Definition Acquired in process research and development + References No definition available. + Details
Name: | syre_AcquiredInProcessResearchAndDevelopment
Namespace Prefix: | syre_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Asset acquisition assets acquired and liabilities assumed net. + References No definition available. + Details
Name: | syre_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet
Namespace Prefix: | syre_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Asset acquisition consideration transferred equity interest issued and issuable, shares. + References No definition available. + Details
Name: | syre_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares
Namespace Prefix: | syre_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Asset acquisition consideration transferred equity interest issued and issuable shares of common stock on an as-converted basis. + References No definition available. + Details
Name: | syre_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableSharesOfCommonStockOnAnAsConvertedBasis
Namespace Prefix: | syre_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fixed exchange ratio. + References No definition available. + Details
Name: | syre_FixedExchangeRatio
Namespace Prefix: | syre_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of employees retained. + References No definition available. + Details
Name: | syre_NumberOfEmployeesRetained
Namespace Prefix: | syre_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Organization consolidation and presentation of financial statements. + References No definition available. + Details
Name: | syre_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems
Namespace Prefix: | syre_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Outstanding and unexercised stock options. + References No definition available. + Details
Name: | syre_OutstandingAndUnexercisedStockOptions
Namespace Prefix: | syre_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of annual equity grant of options to purchase outstanding shares of common stock. + References No definition available. + Details
Name: | syre_PercentageOfAnnualEquityGrantOfOptionsToPurchaseOutstandingSharesOfCommonStock
Namespace Prefix: | syre_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Placement agent and other offering expenses. + References No definition available. + Details
Name: | syre_PlacementAgentAndOtherOfferingExpenses
Namespace Prefix: | syre_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479908/805-50-55-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 25 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 30 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 30 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2 + Details
Name: | us-gaap_AssetAcquisitionConsiderationTransferred
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 45 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480555/946-210-45-21 Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 45 -Paragraph 20 -SubTopic 210 -Topic 946 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480555/946-210-45-20 + Details
Name: | us-gaap_Cash
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4 + Details
Name: | us-gaap_CashAndCashEquivalentsAtCarryingValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of warrants or rights outstanding. + References No definition available. + Details
Name: | us-gaap_ClassOfWarrantOrRightOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of common shares issuable upon conversion for each share of preferred stock to be converted. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 + Details
Name: | us-gaap_PreferredStockConvertibleConversionRatio
Namespace Prefix: | us-gaap_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | instant

X
- Definition Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_PreferredStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromIssuanceOfPrivatePlacement
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of positions eliminated during the period as a percentage of total positions eliminated during the period in connection with the restructuring plan(s). + References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share or per unit amount of equity securities issued. + References No definition available. + Details
Name: | us-gaap_SharesIssuedPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 4 -Subparagraph (SAB Topic 4.C) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-4 + Details
Name: | us-gaap_StockholdersEquityReverseStockSplit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=syre_USBankingInstitutionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=syre_ParapyreOptionObligationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=syre_SeriesANonVotingConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AssetAcquisitionAxis=syre_AssetAcquisitionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=syre_Spyre2023EquityIncentivePlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AssetAcquisitionAxis=syre_SpyreTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |